Home » Topics » BioWorld Science

BioWorld Science
RSS

New antiviral agents prepared and tested at Bayer

June 22, 2004

Further preclinical data on antirheumatic disease activity of AGIX-4207

June 22, 2004

FDA accepts Genmab IND for phase I/II study of HuMax-CD20 in CLL

June 22, 2004

Guilford licenses U.S. rights to GPI-1485 to Symphony Neuro Development Company

June 22, 2004

Enrollment complete in phase IIa trial of DG-031 for heart attack prevention

June 22, 2004

IPL-512602 fails to meet primary endpoint in asthma study

June 22, 2004

Prosidion to acquire DPP-IV platform from Probiodrug

June 22, 2004

PRDT's ligand technology binds and removes viruses from blood product

June 22, 2004

Phase II data supports progression of Onyvax-P for advanced prostate cancer

June 22, 2004

Wyeth and Karo Bio extend collaboration, advance lead compound

June 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...